Pharmacopeia Committee

Tasks of the Pharmacopoeial Committee

  • Evaluation of regulatory documents for medicinal products subject to registration and renewal of registration.
  • Systematic review of regulatory documents for medicinal products with the aim of improving their quality and enhancing analytical control methods.
  • Evaluation and preparation for approval of amendments and revisions to regulatory documents.
  • Participation in international scientific and technical cooperation in the field of medicinal product standardization.
  • Preparation for publication of the State Pharmacopoeia of the Republic of Uzbekistan.
  • Review and preparation for approval of standards defining procedures for the development and establishment of quality requirements for medicinal products, as well as examination, preparation of conclusions, and coordination of draft national standards (O‘zDSt) for medicinal products.

The Pharmacopoeial Committee, in accordance with Resolution No. 738 of the Cabinet of Ministers of the Republic of Uzbekistan dated November 24, 2025, «On Approval of the Regulation on the Procedure for State Registration of Medicines and the Regulation on the Procedure for State Registration of Medical Devices»:

  • Conducts evaluation of the administrative, chemical, pharmaceutical and biological sections of medicinal product registration dossiers, including laboratory testing protocols.
  • Requires applicants to include alternative and/or additional specifications, acceptance criteria, and testing methods in draft regulatory documents for medicinal products in order to harmonize them with national and international requirements.
  • Conducts evaluation and re-evaluation of pharmacological documentation and/or medicinal product dossiers with the involvement of independent experts.
  • Submits samples and documentation of medicinal products to the laboratories of the State Center.
  • Approves regulatory documentation for medicinal products and medical devices.
  • Based on the submitted documentation and expert conclusions, submits to the Expert Council, established by the Ministry of Health of the Republic of Uzbekistan in accordance with the established procedure (hereinafter referred to as the “Expert Council”), recommendations regarding the registration of medicinal products or refusal to register such products.

The Pharmacopoeial Committee maintains continuous cooperation with the WHO on the regulation of medicinal product circulation in the Republic of Uzbekistan, as well as collaboration with CIS member states and other foreign countries in the fields of pharmaceuticals and healthcare. In accordance with Article 8 of the Law of the Republic of Uzbekistan «On Medicinal Products and Pharmaceutical Activities»: «The development of general pharmacopeial articles and their inclusion in the State Pharmacopoeia shall be carried out by the Ministry of Health of the Republic of Uzbekistan in the prescribed manner». «The State Pharmacopoeia shall be published by the Ministry of Health of the Republic of Uzbekistan at least once every five years. During the period between reprints of the State Pharmacopoeia, supplements to the State Pharmacopoeia shall be published». Volume I of the State Pharmacopoeia of the Republic of Uzbekistan was developed by the Pharmacopoeial Committee and approved by Order No. 227 of the Minister of Health of the Republic of Uzbekistan dated August 28, 2020.
The Pharmacopoeial Committee has initiated the development of general pharmacopoeial monographs for inclusion in the State Pharmacopoeia.
For example:
Bacterial Endotoxins — GPM 42 Uz-0001-1010-2020
Determination of Histamine-Like Substances — GPM 42 Uz-0002-1904-2017
Pyrogenicity — GPM 42 Uz-0003-2338-2016
Abnormal Toxicity — GPM 42 Uz-0004-2339-2016

The Pharmacopoeial Committee has developed requirements for medicinal products in accordance with scientific and technological advances aimed at improving the quality and quality assurance of medicinal products for the benefit of consumers.
Particular importance is attached to strengthening requirements and harmonizing technical regulations and regulatory documents developed to ensure the efficacy and safety of medicinal products, medical devices, and medical equipment with The International Pharmacopoeia, The European Pharmacopoeia, The United States Pharmacopeia, and other internationally recognized pharmacopoeias. Approved regulatory documents have been harmonized with international requirements.
For the implementation of the Law of the Republic of Uzbekistan «On Technical Regulation», the Pharmacopoeial Committee established a fund of regulatory documentation in both electronic and hard-copy formats containing more than 14,000 regulatory documents related to medicinal products.
In implementation of this Law, and for the purpose of establishing uniform safety requirements for medicinal products, the Pharmacopoeial Committee developed the General Technical Regulation on the Safety of Medicinal Products, approved by Resolution No. 365 of the Cabinet of Ministers of the Republic of Uzbekistan dated October 27, 2016.

See also other products:


See also:


See also other state duties:


See also:


See also departments:




Registration Department After acceptance of a...
Pharmacological Committee Approval of instructions for...
Pharmacopoeial Committee Evaluation of regulatory documents for...
Committee on New Medical Technology (CNMT) Recommendation for State registration...
Laboratory for quality control and standardization of medicines State quality control of...
Laboratory of vaccines, serous drugs and microbiological research Conducts quality control of...
Laboratory for quality control of medical devices and medical equipment Obtaining reliable and objective...
Laboratory of Pharmacotoxicological Research Review of regulatory documentation...
Department of Pharmacovigilance (PV Dept) Conducting pharmacovigilance...
Department for the implementation of special digital markings In accordance with Resolution...
Quality Management Systems Certification Body The Quality Management System...
Reference Pricing Department In accordance with Resolution...